Earlier studies confirmed that CAP1, a homolog of CAP2, is overexpressed in many cancers, and its expression was correlated with tumor grades in human epithelial ovarian cancer and glioma [19,21], and with the degree of malignancy in glioma [22]. This evidence concerns the gene CAP2 and neoplasm.